132 related articles for article (PubMed ID: 688223)
1. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.
Barlogie B; Göhde W; Johnston DA; Smallwood L; Schumann J; Drewinko B; Freireich EJ
Cancer Res; 1978 Oct; 38(10):3333-9. PubMed ID: 688223
[No Abstract] [Full Text] [Related]
2. Heredity and cancer in man.
Knudson AG; Strong LC; Anderson DE
Prog Med Genet; 1973; 9():113-58. PubMed ID: 4351406
[No Abstract] [Full Text] [Related]
3. Cytometric evidence of cytogenetic and proliferative heterogeneity of human solid tumors.
Nervi C; Badaracco G; Maisto A; Mauro F; Tirindelli-Danesi D; Starace G
Cytometry; 1982 Mar; 2(5):303-8. PubMed ID: 7075395
[TBL] [Abstract][Full Text] [Related]
4. A profile of DNA ploidy status and proliferative activity of solid tumors.
Kresno SB; Harjanto SH; Haryono SJ; Wiyono H; Muryanto H; Winarti D
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():505-13. PubMed ID: 10895202
[No Abstract] [Full Text] [Related]
5. Clinical and biological significance of aneuploidy in human tumours.
Friedlander ML; Hedley DW; Taylor IW
J Clin Pathol; 1984 Sep; 37(9):961-74. PubMed ID: 6381555
[TBL] [Abstract][Full Text] [Related]
6. Comparative flow cytometric DNA analysis on fresh and paraffin-embedded tumor tissue in different neoplasms.
Niezabitowski A; Lackowska B; Ryś J; Dyba T; Gruchała A; Szklarski W; Stelmach A; Kruczak A; Swiatkiewicz I
Pol J Pathol; 1994; 45(3):203-8. PubMed ID: 7953437
[TBL] [Abstract][Full Text] [Related]
7. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.
Frankfurt OS; Slocum HK; Rustum YM; Arbuck SG; Pavelic ZP; Petrelli N; Huben RP; Pontes EJ; Greco WR
Cytometry; 1984 Jan; 5(1):71-80. PubMed ID: 6199167
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids.
Sinton EB; Carver RK; Morgan DL; Philpott PJ; Truell JE; Riemann D; Ashton ME
Arch Pathol Lab Med; 1990 Feb; 114(2):188-94. PubMed ID: 2302036
[TBL] [Abstract][Full Text] [Related]
11. Differential pattern of DNA-aneuploidy in human malignancies.
Büchner T; Hiddemann W; Wörmann B; Kleinemeier B; Schumann J; Göhde W; Ritter J; Müller KM; von Bassewitz DB; Roessner A
Pathol Res Pract; 1985 Jan; 179(3):310-7. PubMed ID: 3856834
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative DNA determination and its role in the prognosis of malignant tumors].
Krug H
Zentralbl Allg Pathol; 1985; 130(4):333-40. PubMed ID: 4090763
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry and prognostic implications in patients with solid tumors.
Williams NN; Daly JM
Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
[TBL] [Abstract][Full Text] [Related]
14. Angioimmunoblastic lymphadenopathy--a malignant disease due to DNA aneuploidy.
Chatelain R; Löhr GW; Böcking A
Anticancer Res; 1989; 9(1):129-31. PubMed ID: 2705741
[TBL] [Abstract][Full Text] [Related]
15. The difference in DNA ploidy pattern between some canine and human neoplasms appears to be genuine and a reflection of dissimilarities in DNA aneuploidy evolution.
Cornelisse CJ; Rutteman GR; Kuipers-Dijkshoorn NJ; Hellmén E
Anticancer Res; 1994; 14(4A):1599-601. PubMed ID: 7979192
[TBL] [Abstract][Full Text] [Related]
16. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].
Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H
Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208
[TBL] [Abstract][Full Text] [Related]
17. [DNA cell content in benign and malignant tumors of various sites].
Petrova AS; Bogatyrev VN
Arkh Patol; 1986; 48(4):86-90. PubMed ID: 3521551
[TBL] [Abstract][Full Text] [Related]
18. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas.
Bauer KD; Merkel DE; Winter JN; Marder RJ; Hauck WW; Wallemark CB; Williams TJ; Variakojis D
Cancer Res; 1986 Jun; 46(6):3173-8. PubMed ID: 3698033
[TBL] [Abstract][Full Text] [Related]
20. [Determination of DNA content by means of cytophotometry. Technical and methodological considerations and its application in tumor pathology].
Roa I; Villaseca M; Wistuba I; Araya JC; De Aretxabala X
Rev Med Chil; 1993 Aug; 121(8):897-902. PubMed ID: 8296097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
